Search This Blog

Wednesday, December 4, 2024

CEO Brian Thompson facing DOJ probe for insider trading when he was killed

 UnitedHealthcare CEO Brian Thompson was one of several senior executives at the company under investigation by the Department of Justice when he was gunned down outside a Manhattan hotel on Wednesday.

Thompson — who was killed in what police called a targeted shooting outside the Hilton hotel in Midtown — exercised stock options and sold shares worth $15.1 million on Feb. 16, less than two weeks before news of the federal antitrust probe went public, according to a Crain’s New York Business report from April.

The stock price dropped sharply after the revelation that the DOJ was investigating whether the company had made acquisitions that consolidated its market position in violation of antitrust laws, a source familiar with the probe told the outlet.

The face of the suspect has been revealed.DCPI
The suspect was last seen entering Central Park, according to officials.
00:03
04:37

Thompson’s stock options reportedly had several years until expiration, and the sale of shares was his first since assuming the helm of parent company UnitedHealth’s insurance division in 2021.

Thompson, 50, along with UnitedHealth Group chairman Stephen Helmsley, Chief People Officer Erin McSweeney and Chief Accounting Officer Tom Roos, sold a combined $101.5 million in shares, with Helmsley personally netting just shy of $85 million, according to the report.

Charles Elson, founding director of the Weinberg Center for Corporate Governance at the University of Delaware, told Crain’s that share sales by firm principals are typically scrutinized by a company’s general counsel, who can determine whether any additional disclosures to the market may be required before the trades are executed.

Earlier this year, UnitedHealth was hit by one of the largest healthcare data breaches in US history, the company estimating as many as one-third of Americans’ private data — potentially including Social Security numbers — were compromised in the ransomware attack.

Police said the killing of Thompson was a targeted shooting outside the Hilton hotel in Midtown.Obtained by NY Post
Crain’s New York Business report revealed in April that Thompson exercised stock options and sold shares worth $15.1 million on Feb. 16, less than two weeks before news of the federal antitrust probe went public.JUSTIN LANE/EPA-EFE/Shutterstock
The report further revealed that Thompson, along with UnitedHealth Group chairman Stephen Helmsley, Chief People Officer Erin McSweeney, and Chief Accounting Officer Tom Roos, sold a combined $101.5 million in shares.AP
UnitedHealthcare CEO Brian Thompson was one of multiple executives who were being investigated for allegedly dumping over $100 million in company stock prior to a federal antitrust probe of the insurance giant becoming public.AP

The company wound up paying the hackers a $22 million ransom, CEO Andrew Witty told a Congressional panel in May.

The massive firm — with annual revenue of around $372 billion — later said it estimated its financial cost as a result of the hack to be around $705 million, Reuters reported.

https://nypost.com/2024/12/04/us-news/slain-unitedhealth-ceo-brian-thompson-was-facing-doj-probe-for-insider-trading-report/

Cidara Starts Phase 2b NAVIGATE Trial Evaluating CD388 for Prevention of Seasonal Flu

 Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced it has reached full planned enrollment of 5,000 subjects in the Phase 2b NAVIGATE trial across clinical sites in the US and UK. The trial is designed to evaluate the efficacy and safety of CD388, the company’s DFC for the pre-exposure prophylaxis of seasonal influenza.

https://www.globenewswire.com/news-release/2024/12/04/2991435/0/en/Cidara-Therapeutics-Completes-Enrollment-of-Phase-2b-NAVIGATE-Trial-Evaluating-CD388-for-Prevention-of-Seasonal-Influenza.html

Ukraine's Yermak meets senior Trump advisers, source says

 A Ukrainian delegation met on Wednesday with senior representatives of President-elect Donald Trump, a source familiar with the meeting said, as Ukraine seeks support from the incoming team in its war to repel Russian invaders.

The Ukrainian delegation was led by Andriy Yermak, a top aide to Ukrainian President Volodymyr Zelenskiy. The group met in Washington with Trump's choice for White House national security adviser, Mike Waltz, and his Ukraine envoy, Keith Kellogg, the source said, without providing details.

The Trump transition team did not respond to a request for comment about the meeting.

Trump has vowed to bring about a negotiated end to the nearly three-year-old conflict between Ukraine and Russia, but has thus far not provided details.

The United States announced on Monday it will send Ukraine $725 million worth of missiles, ammunition, anti-personnel mines and other weapons as President Joe Biden's outgoing administration seeks to bolster Kyiv in its war with Russian invaders before leaving office on Jan. 20.

https://www.marketscreener.com/news/latest/Ukraine-s-Yermak-meets-senior-Trump-advisers-source-says-48525192/

Trump will be interviewed by NBC for Sunday's 'Meet the Press' program

 U.S. President-elect Donald Trump will be interviewed on NBC's "Meet the Press" program, which will air on Sunday, the network said in a statement.

It said the interview would be conducted on Friday and excerpts would be released prior to Sunday's broadcast.

https://www.marketscreener.com/news/latest/Trump-will-be-interviewed-by-NBC-for-Sunday-s-Meet-the-Press-program-48525320/